Phase II trial of afatinib in patients with EGFR-mutated solid tumors excluding lung cancer: results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A

K. Reckamp, Z. Song, S. Gettinger, E. P. Mitchell, J. J. Wright, J. A. Moscow, R. J. Gray, V. Wang, L. M. McShane, L. V. Rubinstein, D. R. Patton, P. M. Williams, S. R. Hamilton, B. A. Conley, C. L. Arteaga, L. N. Harris, P. J. O'Dwyer, A. P. Chen, K. T. Flaherty

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)S84-S85
JournalEuropean Journal of Cancer
StatePublished - Oct 2022
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this